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Objectives:  Empirical  research  shows  that  patients  with  severe  illnesses  prefer the  physi-
cian to dominate  decision  processes  and  provide  the  information  needed.  However,  in rare
diseases,  due  to  the  low  prevalence  and  the  lack  of expertise,  the  patient  is forced  to  become
knowledgeable  about  his own  disease  state.  Objectives  of this  study  were  to  describe  the
experiences  of  patient–physician  interaction  in  rare  diseases,  to develop  an  empirically
derived  typology  of  interaction  patterns  and  to  explore  the  antecedents  of  these  interac-
tion patterns,  with  a special  focus  on role  behavior.  Building  on  these  results,  implications
for  health  care  policy  are  made.
Methods:  We  designed  an  exploratory  study  as  a series  of  semi-standardized  interviews
with patients  suffering  from  rare  diseases.  We  extracted  the  following  six  rare diseases:
amyotrophic  lateral  sclerosis,  Duchenne  muscular  dystrophy,  epidermolysis  bullosa,  Mar-
fan  syndrome,  neurodegeneration  with  brain  iron  accumulation  and  Wilson’s  disease.  A
total  of  107  interviews  were  recorded,  transcribed  and  analyzed  thematically  in accordance
with the  grounded  theory  tradition.
Results:  As  suggested,  insufﬁcient  expertise  of  the  healthcare  providers  proved  to  be  a major
problem  in the  highly  specialized  treatment  process  of rare  diseases.  Here,  the  patient  often
becomes  an  expert  in  his  disease.  Therefore,  we  identiﬁed  the  patient-directed  interaction
as a  widely  experienced  communication  pattern  among  patients  with  rare  diseases.  Our
study also  showed  that  role  discrepancies  have  a  major  impact  on  communication  processes
in  this  context.
Conclusions:  People  with  rare  diseases  often  face  challenges,  due  to  the  low  prevalence  and
the resulting  lack  of  knowledge  of  their  healthcare  providers.  Communication  processes  in
this  context  are  mainly  affected  by  the  role  behavior  of  both  the  patient and  provider.  The
present study  showed  the  relevance  of  the  provider’s  ability  to  acknowledge  the  active  role
of  the  patient  as  an  informed,  involved  and interactive  partner  in  the  treatment  process.
However,  allowing  the  patient  to control  therapy  may  require  a change  of mind-set  with
some long-standing  traditional  roles  in  healthcare.
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1. Introduction
Patient–physician interaction has been a topic of great
interest to research in the medical ﬁeld (e.g., [1–5]).
Evidence indicates that effective patient–physician inter-
action is beneﬁcial to several outcomes [3,6–8].  Moreover,
failures in effective communication between physicians
and patients can lead to increased medical costs arising
from overuse or misuse of medical services [9–11].
Traditionally, the patient–physician relationship
focuses on the information asymmetry between the
patient and physician [12], assuming that the physician
dominates the medical encounter, whereas the patient is
given a more passive role in the treatment decision pro-
cess. Yet, in cases of rare diseases, the patient–physician
relationship may  not ﬁt with the traditional assumptions
of medical care. Although the communication process
between patients and their physicians shares most of the
general features of the standard doctor–patient interaction,
rare diseases may  be burdened with additional problems,
e.g., the lack of disease-related expertise among the health
care professionals, the psychological challenges associated
with the diagnosis of an incurable disease and greater
geographical distances between patients and physicians
[13]. Empirical research shows that patients with severe,
incurable illnesses seem to prefer the physician to dom-
inate decision processes and provide the information
needed [14]. However, due to the low prevalence and the
lack of expertise, patients are forced to become knowl-
edgeable about their own disease and related therapies.
There is a signiﬁcant shift in the traditional roles in the
medical encounter and the patient–physician relationship.
However, despite these challenges, to the best of our
knowledge, little research has empirically explored the
nature of communication processes in the context of
rare diseases, and it remains unclear what constitutes an
adequate partnership between patient and physician in
the speciﬁc context of rare diseases. The existing literature
on rare diseases primarily originates from the research of
medical specialists and is therefore highly disease oriented
[15].
We aim to contribute to the understanding of the
patient–physician interaction in the context of rare dis-
eases. Particularly, we seek to differentiate and to integrate
the various taxonomies that describe role behavior in this
context and its link to patient–physician interaction. This
information is important because knowledge of mutual
role expectations and the resulting interaction patterns can
shed light on the challenges in patient–physician interac-
tion in rare diseases and thus help to identify appropriate
strategies and tools to overcome problems and obstacles
in this area and to increase satisfaction of both patient and
physician. This, in turn, may  help to improve patient out-
comes and to reduce costs by increasing the efﬁciency and
quality of health care services.
Accordingly, the following three central research ques-
tions will guide the current exploratory study: (1) how
does role behavior of both the patient and physician inﬂu-
ence the patient–physician interaction in rare diseases?
(2) What interaction patterns can be observed between
patients suffering from rare diseases and their physicians? 105 (2012) 154– 164 155
(3) What are the consequences of the interaction patterns
identiﬁed on the treatment process?
The paper is structured as follows. First, we brieﬂy
review theory about patient–physician interaction. Second,
we explain the major challenges associated with rare dis-
eases, focusing on role behavior in the medical encounter.
Having explained the research context and design, we
ﬁnally present and discuss the empirical results.
1.1. Theoretical background
1.1.1. Communication in the medical encounter
Several studies have shown that the physician–patient
relationship can play a crucial role in directly inﬂuencing
patient’s health and well-being through the patient’s
sense of feeling understood as well as indirectly through
continuity of care and adherence to treatment regi-
men  [3,6,8,16]. Physicians’ professional credibility and
competence, as well as the appropriateness of commu-
nication, signiﬁcantly determine patients’ psychological
status, physiological symptoms and functional outcomes
[6,17–19]. The accumulated evidence indicates that
patient-centered communication, including information-
giving and information-seeking behavior and patient
involvement in the treatment process, can alleviate
patients’ feelings of uncertainty and can even affect the
healing process [20–22].  Although the patient–physician-
relationship may  be inﬂuenced by various individual
attributes [23–27],  it is not only a function of personal
inﬂuences; according to Street and colleagues, it is also “a
process of mutual inﬂuence” [28].
Many descriptive models have been applied to relation-
ships between patients and physicians [4,29,30]. They are
determined by the degree of control exercised between
the patient and the provider. Two  prominent approaches
are the paternalistic model, with the physician having the
dominant role, and the informative model in which the key
responsibility of the physician is to provide the medical
expertise [4,12,17]. Another widely advocated interpre-
tation of the doctor–patient relationship is the model of
shared-decision-making. In this model, the patient and the
physician equally exchange information across all stages
of the decision-making process [4,12,31]. Moreover, recent
conversation analysis studies suggest that communication
may  differ according to the various phases of the medical
interview [32].
The assumption underlying each of these models is
that the physician has sufﬁcient expertise regarding the
diagnosis and treatment. However, in the context of rare
diseases, physicians often lack knowledge and experi-
ence, and, therefore, patients are faced with a high degree
of uncertainty. Particularly, most treatments are consid-
ered experimental, which leads to questions about their
safety and effectiveness [33]. Information may  be incon-
sistent or contradictory, and the patient is faced with the
numerous treatment option opinions of the involved health
care providers. Ambiguity, variety and unpredictability of
symptoms represent further problems [34–39].  Therefore,
the traditional roles within the patient–physician interac-
tion may  change. This, in turn, can lead to differing mutual
role expectations resulting in role discrepancies.
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.2. A role theory perspective on the medical encounter
According to Ebaugh, roles are “sets of behavioral
xpectations associated with given positions in the social
tructure” that may  be achieved or ascribed [40]. Thus, role
heory constitutes a key element in understanding rela-
ionships between individuals [41–43].  There have been
wo distinct approaches of role theory in the sociological
iterature [40]. In the structural tradition, roles are typically
eﬁned as socially shared expectations and behaviors asso-
iated with given positions in the social structure [44–47].
hrough the process of role-taking, the individual rec-
gnizes and internalizes those expectations. Interactional
heories, in contrast, assume that roles are created and
edeﬁned, as individuals actively construct, interpret and
niquely express them. Role-making processes are central
o understanding this approach. In the current analysis of
oles in the medical encounter, we draw on De Rue and
shford, who combined these two distinct yet comple-
entary approaches and proposed that identity work is
ndertaken both by an individual claiming an identity and
y others afﬁrming and reinforcing (or not) that identity
36].
Sluss and Ashforth presented a conceptual framework
n which role identity constitutes a central attribute of
he relationship between two individuals [49]. To the
xtent that roles become socially constructed in interac-
ion with others, role theory occupies a central place in
esearch on interactions in the service encounter. Each
ndividual in the service encounter has a role to per-
orm [48]. The service encounter in health care may  thus
e approached as a special case of role performances in
hich both the patient and physician act as social actors
ppropriate to their position in this relationship. Once the
atient enters the medical encounter, he or she adopts
he role of patient, and a role-deﬁned dyadic interaction
ay  begin. The course of the medical encounter is gov-
rned by traditional behavior patterns. As such, the role
f the physician is to provide information concerning the
atient’s illness, whereas the patient is assumed to bring
n his or her health history, expectations and needs. If role
erceptions vary between doctor and patient, conﬂicts and
sociomedical dilemmas” [32] may  arise and lead to frus-
ration [50].
However, in rare diseases, the medical encounter is
nﬂuenced by changes in the traditional role structures. Due
o poor knowledge of rare diseases and the limited ther-
peutic options of treatments, physicians may  not act as
ompetent technical experts who provide relevant infor-
ation to the patients. The patients are thus forced to
ecome experts on their own disease state. Therefore,
oth parties must revise their role identities and mutual
xpectations. However, professional role identity is highly
esilient and resistant to change [51,52].  As a result, in an
nvironment without existing routines and limited expe-
ience, the physician’s role concept probably differs from
hat projected by the patient [53]. In light of research
ndicating that the associations between mutual relational
xpectations and the communication process in the medi-
al encounter are complex, we aim to offer new approaches
o understand this link [28]. Ta
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2. Materials and methods
To answer the abovementioned explorative research
questions, an interpretive, qualitative approach was
selected. This approach allowed us to describe and under-
stand patients’ behavior and its implications for social
interaction [54]. We  considered this approach consistent
with both our research goals and the methodology and
assumptions used in recent research on related topics (e.g.,
[55–57]).
The study was conducted in a sample of patients in
Germany. Through expert interviews with various physi-
cians who specialize in the care of rare diseases and with
representatives of self-help organizations, we extracted
the following six rare diseases that mainly differ in care
intensity, patients’ age of disease outbreak (children vs.
adults) and prevalence: amyotrophic lateral sclerosis (ALS),
Duchenne muscular dystrophy (DMD), epidermolysis bul-
losa (EB), Marfan syndrome, neurodegeneration with brain
iron accumulation (NBIA) and Wilson’s disease. These dis-
eases are characterized by regionally dispersed expertise,
limited experience, a degree of uncertainty due to an
absence of knowledge and routines and extraordinary indi-
vidual health care demands. Patients were sampled via
ACHSE (Allianz Chronischer Seltener Erkrankungen), which
is a non-proﬁt association for the needs of people with rare
diseases, and through centers of expertise and specialized
hospitals for rare diseases.
Our analysis includes a total of 107 semi-standardized
interviews with patients from Germany. Table 1 displays
selected demographic and health characteristics of the sub-
jects.
In some cases, family members were integrated in the
interviews, e.g., in cases of pediatric patients or patients
with limited speech ability. In sum, we conducted 34 inter-
views with parents of ill children and 73 interviews with
adult patients. The questions that guided the interviews
were broad and open-ended and pertained to the expe-
riences patients had in the medical encounter and to the
interaction processes with their healthcare providers. New
questions emerged with time as a function of the evolving
results of the analyses. The interviews lasted between 30
and 45 min  and were tape-recorded and transcribed ver-
batim.
The analysis was designed in accordance with rec-
ommendations of qualitative research and followed the
grounded theory approach of comparing and contrasting
the data and the emerging theory throughout the data
collection and analysis process [58–60].  We  analyzed the
transcribed interviews using Atlas.ti version 6.2, software
for content analysis. In a ﬁrst step, we derived in vivo codes
inductively from the interviews and subsequently created
ﬁrst-order categories. As our coding progressed, associa-
tions between these initial categories were determined,
and further subcategories emerged. Finally, by continually
aggregating and consolidating our categories, we obtained
abstract theoretical dimensions that revealed interaction
processes between patients and their physicians, as well
as their antecedents and consequences. In order to ensure
that the emerging categories ﬁt the data, a representative
sample of 10 transcripts was double-coded by a second 105 (2012) 154– 164 157
researcher. Fig. 1 shows the development of the cate-
gories.
3. Results
To help make sense of the resulting dimensions of
interaction processes between patients and physicians in
cases of rare diseases and their relationships in the current
data, we  propose a theoretical model (Fig. 2). The model
shows how the role behavior and individual competen-
cies of both the patient and physician combine to form the
patient–physician interaction in the medical encounter.
In describing these ﬁndings, we begin with a discus-
sion of role behavior and individual competencies of both
the patient and physician. Next, we  continue by addressing
how these individual factors are intertwined with commu-
nication processes in the medical encounter. Finally, we
outline four distinct interaction patterns that were identi-
ﬁed in the current study.
3.1. How are role behavior and patient–physician
interaction in rare diseases related?
Role behavior can be described by the role identity and
role expectations of patients and physicians. Role identity
is deﬁned as a constellation of goals, values, beliefs, norms
and experiences that are related to a role [61]. Therefore,
certain patients show more passive attitudes in the med-
ical encounter [62], whereas others regard themselves as
experts seeking an active role in medical treatment and
decisions:
“To a large extent, I am my  own expert, because I know
best what I need and what helps me.” [MA21]
We found that the majority of physicians acted as the
patient’s partner in the medical encounter. However, a
minority of physicians rejected the patient’s assertive
behavior, demonstrating an almost arrogant attitude
toward the patient:
“The school doctor thinks that he knows more than we
parents do, and he always tries to make our decisions
look bad.” [DU20]
Role expectations reﬂect expected behaviors of actors in
complementary social positions [50]. Missing congruence
between the perceived and the expected behavior leads
to role discrepancies and conﬂicts. If both the patient and
physician share mutual role expectations, they enact their
prescribed roles of patient and physician through the pro-
cess of role taking. However, the current data indicated that
contextual uncertainty may  inﬂuence these ritualized roles
and lead to role transitions. These, in turn, have an impact
on the patient–physician interaction. Our study revealed
that, in the context of rare diseases, role discrepancies
arise: physicians had to cope with lacking, insufﬁcient or
ambiguous knowledge. Patients also found themselves in
a dilemma. Although they approached the physician to
receive help, they were forced to assume the expert role
and provide information to the physician:
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Physician´s
role behav ior
Physician´s
compe tence
Physician´s
role identity
Patien t´ s
role identity
Unce rtainty
man agemen t
Disease-related
expertise
Social
compe tencies
Unce rtainty
man agemen t
Desc riptions of
patien t-physician
interaction
Information-tr ansfer
proces ses
Decision-making
proces ses
First-order Categories
(examples) 
Sec ond-Order Theme s Aggregated Theoretical Dimensi ons
Patient providing the phys ician with
information; well-informed physician
Prog nosis; prog ression; curab ili ty
Ambiguity
Severity
Disea se-related
charac teristics
Shared de cision-making ; phys ician taking the
decision; no nee d for decisions
Wishing to be taken by the hand by the
physician; accep ting physician´s authority
Technical expe rt;  pa tient´s pa rtner; 
patient´s guardian
Physician´s ad visor;  pas sive  consumer
Physician ac cep ting pa tient´ s expe rtise; 
rejecting pa tient´ s ob jections
Information-seeking initiatives ; adap tation to
uncertainty; proa ctive be hav iour
Abil ity to cop e with dea th; sensibility; 
empa thy; commun icational abil ities
Expe rience with pa tient´s disease ; disea se-
related knowled ge
Heteroge nity of symptoms; difficult diag nose ; 
inconsistent information
Disea se-related knowledge ; expe rience
Patien t´ s
role behav ior
Physician´s role
expectations
Patien t´ s role
expectations
Patien t´ s
compe tence
Disease-related
expertise
Social
compe tencies
Commun ication al ab ilities; ass ertiveness
Information-seek ing initiatives; creation of new
idea s
Fig. 1. Development of coding categories.
Paent-physician
interacon
Rol e beha vior
Competence
Role expectaons
Role id enty
Individual level
(pa entan dphys ician)
Informaon-tran sfer
processes
Decision-making process es
Contextual level
Diseas e-relat ed un certa inty
Interacona l level
Uncertainty manag ement
Disease-related exp erse
Social competencies
Role-taking
Role-making
Disease aribut es
Fig. 2. Patient–physician interaction and its antecedents.
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Table 2
Distribution of the interaction patterns in the sample.
Patient-directed Interaction pattern
Collaborative Physician-directed Confrontational TotalParticipants, N 33 (36%) 49 (54%) 
Adult  patients 21 (32%) 37 (56%) 
Parents 12 (46%) 12 (46%) 
“Actually, you’re in a bit of a bind because you contact a
professional to get help, but at the same time you need
great sensitivity in the communication; otherwise, he
might feel offended.” [MA43]
Another challenge resulting from role discrepancies arises
if the patient, although not a medical expert, is better
informed about possible treatment options than his physi-
cian. Because the patient is well aware of the physician’s
higher authority, this situation might constitute a problem
for the patient:
“I am not a medical expert, and I cannot simply tell her
that I would like to try that out because it might work
. . . Actually, you need a lot of ﬁngertip feel.” [NB14]
Because of these differing expectations and the resulting
discrepancies, role-taking processes must be completed by
role-making processes. Consequently, both patients and
physicians are involved in an ongoing process of actively
creating, adapting and modifying their roles based on the
situation and their mutual expectations [63]. Particularly
when confronted with patient assertiveness and engage-
ment, physicians often need to adjust their professional
role identity and behavior. The present data revealed that
some physicians feared that patient empowerment would
threaten their social power. Because of their limited expe-
rience, they were not able to cope with the newly emerging
role of the “expert patient” [64], as indicated by the follow-
ing statements:
“It has frequently been my  experience that the doctor
asked me,  who was the doctor - him or me.” [EB05]
In addition, the patient also had to adjust to the newly
emerging roles in the medical encounter. We  found evi-
dence that the majority of patients with rare diseases
learned to fulﬁll their role as experts in the treatment
process, actively pursuing multiple types and sources of
information for new data related to their disease and shar-
ing these insights with the physician:
“I have explained the disease to my  GP.” [EB02]
3.2. What interaction patterns between patients
suffering from rare diseases and their physicians can be
observed?
The study revealed a variety of patients’ experiences
in the medical encounter. We  aggregated the descriptions
of these experiences and ﬁnally identiﬁed four interaction
patterns. The main factors that differentiated these pat-
terns were their particular conceptions of the underlying
processes of information-exchange and decision-making.6 (6%) 4 (4%) 92
5 (7%) 3 (5%) 66
1 (4%) 1 (4%) 26
Table 2 shows the distribution of the interaction patterns
among the patients.
We address these patterns in the following sections.
The paternalistic pattern of patient–physician inter-
action has been widely described in the literature
[4,12,30,32]. This model assumes that the physician dis-
cerns what is in the patient’s best interest, therefore
minimizing the patient’s participation. In the current study,
patients often preferred not to participate in the treat-
ment’s decision-making process, believing that decisions
require expertise and medical experience that they lack.
Thus, they relied solely on the doctor’s opinion. As such,
the paternalistic approach that emerged from the present
data was characterized by a mutual approval of the physi-
cian’s authority and thus by role congruence. This ﬁnding
is in line with prior research that suggests that being
confronted with a serious and potentially life-threatening
illness leads to a delegation of responsibility to the physi-
cian [29,67]. The current ﬁndings strongly support this
implication:
“We  did not discuss it; it was  the doctor who decided for
us. We  did not question his opinion; he is the expert.”
[DU10]
“Actually, you’re getting told what to do next, and I think
that the physicians know more than I do.” [MA27]
The collaborative pattern is distinguished by equal levels of
medical information exchange between the parties and a
mutual agreement on the treatment. Thus, this interaction
type corresponds in the most part to the widely known con-
cept of shared decision making [4,12,32,68–70].  However,
this pattern includes another important aspect, namely,
the patient’s self-acquired expertise and the physician’s
acknowledgment of this expertise. The present research
supports previous ﬁndings that patients attempt to develop
relevant knowledge to manage their illness and con-
ditions through information-seeking activities [71]. The
majority of physicians encourage the patient’s engage-
ment because it may  contribute to a common deﬁnition
of the medical problem and build a collaborative rela-
tionship between the parties [72]. Thus, there is mutual
comprehension of the roles both parties play in the medi-
cal encounter. The following examples illustrate this type of
interaction:
“We  are always working out together what is right in
therapy.” [AL12]
“I am getting involved by my  doctor; he asks me  what I
want and how I would like to proceed.” [DU14]
The patient-directed interaction pattern is apparent in the
patient’s engagement and the large amount of information
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e provides the physician. In contrast to the collabora-
ive pattern, in this case, the physician does not have any
xpertise about the disease. Therefore, the patient needs
o acquire knowledge on his or her own disease state and
nstruct the physician on the treatment options. In this
ituation, the physician is a passive participant, and his
nvolvement is often limited to providing consent for the
reatment advocated by the patient or to writing prescrip-
ions. Therefore, the patient and physician both actively
reate and modify their roles based on the situation:
“Our family doctor does not know anything about my
disease, and he relies on my  opinion.” [DU15]
“Actually, the way it works in EB is that you go to a physi-
cian and you explain to him what you want and what
you need.” [EB09]
inally, the confrontational interaction pattern reﬂects a
onﬂict situation. In this case, the patient seeks an active
ole in the medical encounter. Because of his expertise, the
atient is able to evaluate and even challenge the physi-
ian’s competence [73]. The physician, however, attempts
o reassert control by authoritatively making decisions and
gnoring the patient’s suggestions and preferences. This
nter-role conﬂict is attributable to different role expec-
ations [41,74].  In extreme cases, the physician questions
he patient’s knowledge and skills, as the following quotes
how:
“Actually, there are few physicians who admit their lack
of knowledge. Many feel offended, and that’s why it’s
getting so difﬁcult: because you have to ﬁght against
them.” [MA06]
“He barked at me  that I should stop acting up. And then
they carried out the operation in a way that was against
my wish.” [EB15]
n line with previous research, which found that communi-
ation between the patient and the physician is inﬂuenced
y personal attributes, the current study also considers
he impact of the individual competencies of both parties
n their interaction. A physician’s communication skills
haping patient-centered care seem to be fundamental
ompetencies leading to a better patient–physician rela-
ionship. Patients expect the doctor to be a competent
artner in discussions:
“It’s important for me  that I can talk to my  doctor.”
[MA08]
“I would like the doctor to also ask some counter-
questions.” [MA20]
he physician’s professional competence, especially his
ask-related and disease-speciﬁc knowledge and expe-
ience, is another crucial factor that inﬂuences mutual
greement [65]. However, in the case of rare diseases,
he lack of knowledge constitutes a major challenge
or patients. If the medical providers do not have any
nowledge about the disease, the patient often takes the
nitiative. Thus, patient-directed interaction is mainly pre-
icted by the physician’s lack of expertise in rare diseases,
s indicated by the following quotes: 105 (2012) 154– 164
“If  you have something to do with people who don’t
know the disease, you have to lay the groundwork for
them.” [MA03]
“I have set myself the goal of informing the doctors.”
[MA07]
Most patients were realistic about what their physician
could provide, and they appreciated honesty about a
physician’s lack of knowledge [66]. The following quotes
illustrate this attitude:
“I would not assume that my  GP knows my disease.”
[AL16]
“This is simply a lack of knowledge, and you cannot
blame anyone for this.” [MA03]
Finally, other personal attributes of the physician that
patients attached importance to are empathy and ability
to cope with imminent death [67]:
“I wished to have a doctor who accompanies me
throughout the illness, without any fear of death.”
[AL22]
In addition, the results suggest the patient’s individual
competence as another antecedent to satisfactory role
enactment and interaction in the medical encounter. For
example, the patient’s ability to cope with the disease-
related uncertainty in conjunction with well-developed
information-seeking skills may  result in higher self-esteem
in enacting the role as an expert patient:
“I am very well informed, and that’s why I can talk with
the doctor at the same level. Actually, I am on a par with
him.” [AL28]
Our results also show differences in the patient–provider-
interaction processes between adults who themselves
were affected by the disease at those who  had a child
with a rare disease. As such, the patient-directed inter-
action pattern is more apparent among parents who
interact with the physician on behalf of their child than
among adult patients. Parents do often engage in seek-
ing information on the disease and providing it to the
physician.
Patients’ diagnosis and health status, along with their
attitude toward their illness, are also likely to play an
important role in the medical encounter. Therefore, the
degree to which patients with rare diseases want to be
involved may  vary according to individual or contextual
characteristics, such as the complexity of the illness or its
prognosis. Patients suffering from Marfan’s syndrome live
in constant fear of an aortic dissection that can happen
at any time. This unpredictability about individual dis-
ease trajectories contributes to patients’ uncertainty and
their fear of observational oversight, increasing their need
for intensive consultation. The ﬁndings of this study also
reveal that patients who  face a fatal and rapidly progres-
sive disease such as ALS or NBIA usually interact with their
physician in a cooperative way, and they often take the
initiative and seek information. In addition, due to the
extremely low prevalence of NBIA, both patient and physi-
cian are confronted with the lack of knowledge about the
th PolicyK. Budych et al. / Heal
disease. Consequently, they work out the best treatment
plan together. Thus, the confrontational interaction pattern
was not observed in these participants.
Another interesting ﬁnding worth noting is the het-
erogeneity of the clinical picture, which may  lead to
uncertainty among physicians and thus to confrontations
between patients and physicians. If a patient’s appearance
or his symptoms do not correspond phenotypically to the
clinical picture as commonly described and known, the
patient may  face a lack of understanding by his health care
providers, which can lead to conﬂicts. Often, physicians
might even question the diagnosis, particularly in the case
of patients with EB or Marfan’s syndrome. As the following
participant stated:
“I don’t look like a typical Marfan patient, and only few
know that there is a wide heterogeneity in appearance.”
[MA31]
If there exists a therapeutic option that might slow the pro-
gression of the disease, patients with rare diseases are often
faced with the problem of numerous opinions among the
providers involved in the treatment. In particular, this can
be observed in parents of children with Duchenne muscu-
lar dystrophy, for which steroids are offered as a treatment
option. Although steroids can be beneﬁcial, there are also
various negative side effects that should be considered
when making the decision to use this treatment. There-
fore, participants in the study often reported uncertainty,
and they wished to discuss the beneﬁts and risks of such an
intervention carefully with the physician to reach a deci-
sion, as indicated by the following statements:
“One professor says this, the other says that.” [DU20]
“We  went back and forth discussing it with our doctor.
Unfortunately, it also has many side effects. However, it
was all discussed with us in detail.” [DU22]
4. Discussion
The objective of the current study was to explore the
experiences of patients suffering from rare diseases in the
interaction with their physicians. The qualitative analysis
outlined a variety of problems these patients must face.
As suggested, the low prevalence of the diseases and the
related insufﬁcient expertise of the healthcare providers
proved to be major challenges in the treatment process. The
experienced contextual uncertainty inﬂuenced the way
the parties interacted with each other, as discrepancies in
mutual role perceptions arose.
Further, we derived four interaction patterns. By
identifying the patient-directed interaction pattern char-
acterized by the role of the patient as an expert on his
own disease state, we extend existing ideas and theories
on patient–physician interaction. In the speciﬁc context
of rare diseases, the patient often becomes the driving
force in the treatment and information-seeking processes.
Therefore, the traditional patient–physician relationship
undergoes a signiﬁcant change. Finally, our research sug-
gests that role transitions encounter greater resistance by
physicians than by patients. 105 (2012) 154– 164 161
As such, we make three contributions. First, by showing
the impact of role behavior on communication between
the physician and patient, we combine role theory with
ideas about interaction in the medical encounter and
thus advance the medical socialization literature. Partic-
ularly, we found that role discrepancies have a major
impact on interaction processes in the medical encounter.
This ﬁnding leads to an extension of the existing mod-
els of patient–physician interaction. Second, we  studied
patient–physician interaction in rare diseases, a context
that has received comparatively little research attention to
date. In doing so, we highlight the challenges and problems
these patients must face. Finally, we contribute to stud-
ies on patient satisfaction by elucidating the relevance of
the provider’s ability to acknowledge the active role of the
patient as an informed, involved and interactive partner in
the treatment process.
The study has also several limitations that should be
considered in future research. The ﬁndings are based
on patient self-reports, thereby raising a question about
external validity. Complementary to the perceptional
approach, further studies using behavioral assessment
of patient experiences (e.g., via audiotape or video-
tape) are warranted to better understand the interplay
between communication and patient satisfaction [68].
Research designs should also measure both the patient’s
and the physician’s perspectives and explore the physi-
cian’s decision-making style. This will enable to analyze
the congruence between decision-making styles of physi-
cian and patient and its impact on patient satisfaction.
Another appropriate avenue for future research on uncer-
tainty in rare diseases would be to conduct interviews
with health care providers to ascertain how they cope
with the perceived limits of medical knowledge. Further-
more, the cross-sectional design of our study does not
allow us to reliably assign any causation to the observed
associations. Therefore, we strongly encourage researchers
to obtain multisource data in longitudinal studies on the
physician–patient relationship in rare diseases [69].
Another limitation worth noting is that we did not
examine the inﬂuence of cultural, ethical and sociodemo-
graphic issues, although these issues have also been found
to contribute to the different perceptions and behaviors of
patients [23–27].  We  suggest that future research should
consider these variables as further potential predictors in
patient–physician interactions in the context of rare dis-
eases. Finally, future research is urgently needed to analyze
and understand the congruence between the actual level of
participation and the preferred pattern of participation of
patients with rare diseases, since this constitutes a major
prerequisite for patient satisfaction [68,70].
4.1. Policy implications
We  believe the results allow us to make several contri-
butions that are particularly relevant to health care practice
and to highlight fruitful avenues for both research and
practical application. The ﬁndings are consistent with the
contention of previous research that communication in
the medical encounter is a multilayer construct, result-
ing in various distinct interaction models. The analysis
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resented in this study extends the understanding of
atient–physician interaction and its elements by reveal-
ng role behavior as a crucial predictor. In particular, we
ropose that the interactional behavior of both the patient
nd physician may  differ according to their role identities
nd mutual role expectations. As such, our model ten-
atively suggests that a focus on individual role-related
henomena can illuminate the factors that inﬂuence both
arties to participate in decision-making and to engage in
nformation-seeking processes.
Furthermore, this study tends to substantiate the shift
n both theory and practice from the traditional model of
atient–physician relationships to one that is character-
zed by patient participation. Although the notion of ‘expert
atient’ is not without controversy, there is broad support
or the idea that patients should be actively involved in
heir health care [75–78].  The present study shows the dif-
culties and importance of providing information about a
are disease. We  found that the vast majority of patients
ith rare diseases wish to have information and to par-
icipate in the treatment process. The patients actively
eek information and might even challenge the physician’s
uthority. Patients should be supported by their providers
n developing the conﬁdence and motivation they need to
se their own skills and knowledge to take effective control
ver living with their disease. These patients may  beneﬁt
rom the mutual exchange with their physician by better
nderstanding their own conditions and by participating
ore effectively in medical interactions. Moreover, the
mproved patient–physician interaction can also enhance
atients’ self-care skills as well as their adherence to treat-
ent [69]. Effective information exchange can also help the
hysician to understand the patient’s preferences and to
nd a solution that best matches the patient’s expectations.
utual collaboration between physicians and patients not
nly affects the health outcomes of patients, it may  also
educe medical costs by increasing the efﬁciency and cost-
ffectiveness of medical visits. In particular, it may  help to
void unnecessary tests and re-admissions – factors that
ontribute signiﬁcantly to increased medical costs [9–11].
Physicians need to recognize that they have a role
n helping patients through the process of accessing
nd understanding information. Therefore, health care
roviders can take advantage of this opportunity to pro-
ote patients’ awareness of illness. For this purpose,
hese providers should be trained to deal with patients
ith rare diseases and they must learn to cope with
ssertive and well-informed expert patients. In particular,
hey must become skilled at communicating in ways that
uild and sustain positive patient relationships by shar-
ng their knowledge openly and by encouraging patients’
elf-reliance. Educational associations and institutions in
ealth care should encourage physicians to practice and
mprove their skills in this area. Our framework suggests
hat attempts to educate, train and support physicians to
romote patient participation need to consider physicians’
nderlying professional role identities and communication
kill sets. Another crucial factor inﬂuencing the satisfac-
ion of patients with rare diseases is related to physicians’
nowledge about the disease. Therefore, health care pol-
cy should create the appropriate regulatory environment 105 (2012) 154– 164
that helps physicians to stay up to date on the medical lit-
erature and new treatments. Examples of providing help
in knowledge acquisition and exchange among medical
professionals include the implementation of a telematic
platform and the pooling of knowledge in centers of exper-
tise.
Although a previous survey conducted on rare disease
patients from 16 European countries conﬁrms that the
problems that these patients face are similar across the
national health care systems, our results must be dis-
cussed in view of the health care system level [79]. A major
challenge in the German health care system is related to
the separation of the ambulant and the inpatient sectors,
which makes the coordination and information exchange
in the treatment of rare diseases difﬁcult. To improve the
treatment of patients with rare diseases, health care pol-
icy makers must refocus their efforts on the broader care
continuum. The establishment of networks of cooperating
experts in various medical specialties may  help to relax the
traditional lines between outpatient and inpatient care.
Patients in Germany enjoy a high degree of free access to
health care and choices among a wide range of specialists.
This is especially beneﬁcial for patients with rare diseases
because it allows them to change their doctor if his commu-
nication style does not correspond with their expectations.
However, our ﬁndings suggest that approaches that have
recently been introduced in Germany to limit the choice
of providers for patients may  further improve the coor-
dination of treatment for patients with rare diseases. In
particular, the gatekeeper role of the GP is crucial in help-
ing patients to ﬁnd highly specialized providers and to
coordinate their treatment. However, a prerequisite of this
improved access to treatment is to provide appropriate
regulatory structures that enable the GP to perform this
task. Because the diagnosis and treatment of rare diseases
require more time, health care policy should create the
appropriate regulatory environment that allows physicians
to spend more time with these patients, for example, by
providing more ﬂexibility, improving physician workﬂow
and creating more efﬁcient processes.
Finally, we suggest the transferability of the ﬁndings to
other diseases. Due to an increasing focus on preventive
health care, improved access to medical information and
the growth of consumerist attitudes in health care, patients
become more actively involved in decisions concerning
their treatment. Further studies in this direction could lend
insight into how physicians deal with the emerging role of
empowered expert patients.
5. Conclusion
People with rare diseases often face challenges, due
to the low prevalence of their diseases and the result-
ing lack of knowledge of their healthcare providers. The
present ﬁndings reveal that the patient–physician relation-
ship undergoes a signiﬁcant change that results in role
discrepancies. The study shows the difﬁculties and impor-
tance of providing information about a rare disease. The
vast majority of patients with rare diseases actively seek
information. Healthcare providers should take advantage
of this opportunity to promote patients’ awareness of their
th Policy
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illnesses. Finally, policy makers must recognize the unique
needs of patients with rare diseases to get support in infor-
mation seeking and in accessing specialists.
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